Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

21.36
+2.1311.05%
Volume:4.21M
Turnover:86.27M
Market Cap:951.61M
PE:-12.95
High:21.37
Open:18.70
Low:18.62
Close:19.23
52wk High:32.71
52wk Low:8.80
Shares:44.56M
Float Shares:24.29M
Volume Ratio:4.50
T/O Rate:17.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6486
EPS(LYR):-1.8100
ROE:-26.16%
ROA:-16.67%
PB:3.71
PE(LYR):-11.80

Loading ...

Beta Bionics price target raised to $27 from $24 at Leerink

TIPRANKS
·
Sep 14

Truist Lifts Price Target on Beta Bionics to $23 From $22, Keeps Buy Rating

MT Newswires Live
·
Sep 14

Analysts’ Opinions Are Mixed on These NA Stocks: Lineage, Inc. (LINE), Beta Bionics, Inc. (BBNX) and Huron Consulting (HURN)

TIPRANKS
·
Sep 14

Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as Its Next-Generation Insulin Dosing Algorithm

THOMSON REUTERS
·
Sep 14

Beta Bionics, - Estimates Fy2026 Total Revenue of $121 Mln-$126 Mln

THOMSON REUTERS
·
Sep 14

Beta Bionics, - Mint Full U.S. Commercialization Expected to Begin in Q1 2027

THOMSON REUTERS
·
Sep 14

Beta Bionics, Inc.: During FY 2027, Expects Mint to Recapture Any Revenue Lost in Q4 2026

THOMSON REUTERS
·
Sep 14

Senseonics Partners with Beta Bionics to Integrate Eversense 365 CGM with iLet Bionic Pancreas

Reuters
·
Sep 14

Senseonics Holdings: Development of Eversense 365-Ilet Integration Expected to be Completed in Q4 2026

THOMSON REUTERS
·
Sep 14

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the Ilet® Bionic Pancreas

THOMSON REUTERS
·
Sep 14

Beta Bionics (BBNX) Faces Securities Lawsuit After iLet Patient-Start Miss and FDA-Related Disclosures

TIPRANKS
·
Sep 11

Beta Bionics Chief Commercial Officer Mark Hopman Disposes of 36,870 Common Shares Worth $680,723.44

Reuters
·
Sep 11

Beta Bionics CEO Sean Saint Disposes of 5,641 Common Shares for $113,261.01

Reuters
·
Sep 05

Beta Bionics Initiated at Market Perform by William Blair

Dow Jones
·
Aug 22

Beta Bionics price target raised to $18 from $15.50 at BofA

TIPRANKS
·
Aug 11

BofA Securities Adjusts Beta Bionics Price Target to $18 From $15.50

MT Newswires Live
·
Aug 11

Dexcom Q2 Revenue Beats Estimates Raises Outlook; Raises FY Revenue and Margin Guidance

Reuters
·
Jul 31

Beta Bionics price target lowered to $30.40 from $32 at Ladenburg

TIPRANKS
·
Jul 30

Analysts Are Bullish on Top NA Stocks: Waystar Holding Corp. (WAY), Beta Bionics, Inc. (BBNX)

TIPRANKS
·
Jul 30

Beta Bionics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30